Depersonalization/realization Disorder
Conditions
Interventions
tDCS_A:F3-FP2
tDCS_B:TP4-left shoulder
Group A:Duluoxetine and escitalopram placebo
Group B:Escitalopram and Duluoxetine placebo
Sponsors
Beijing Anding Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Study 1: (1) According to ICD-10 diagnostic criteria of depersonalization realistic disintegration syndrome; (2) Aged 18-40 years (including 18 and 40 years); (3) Right handed; (4) Voluntary informed consent and compliance with the research protocol; (5) Understanding the follow-up questionnaire survey. Study 2: (1) According to ICD-10 diagnostic criteria of depersonalization realistic disintegration syndrome; (2) Aged 18-40 years (including 18 and 40 years); (3) voluntary signing of informed consent and being able to comply with the research protocol; (4) understanding the follow-up questionnaire survey.
Exclusion criteria
Exclusion criteria: Study 1 (1) There are serious suicidal tendency; (2) Depression secondary to other mental or physical diseases; (3) Patients with severe or unstable heart, liver, kidney, endocrine, blood and other medical diseases; (4) Regular use of large doses of benzodiazepines; (5) Combination of psychiatric drugs; and (6) The presence of brain organic damage. Study 2 (1) There are serious suicidal tendency; (2) Depression secondary to other mental or physical diseases; (3) Patients with severe or unstable heart, liver, kidney, endocrine, blood and other medical diseases; (4) Regular use of large doses of benzodiazepines; (5) Combination of antipsychotics or mood stabilizers; (6) Presence of brain organic damage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptoms assessment;assessment of cognition function; | — |
Countries
China
Contacts
Public ContactZhu Hong
Beijing Anding Hospital, Capital Medical University
Outcome results
None listed